Menu

Gossamer Bio, Inc. GOSS

Full chart Compare
Set alert

Price alert · GOSS

All alert types
9.77 USD +0.35 (+3.72%)

At closeNov 6, 2026, 7:30 PM EST

9.88 +0.11 +1.13%

After hours · Nov 6, 7:30 PM ET

9.27 Day range 9.99
8.43 52-week range 303.20
YTD
-96.06%
1 year
-94.71%

Revenue & Expenses

Other Operating Income → Expenses: $1.00MIncome Tax Benefit → Expenses: $88.00KExpenses → Selling, General & Admin: $37.63MExpenses → Research & Development: $174.09MExpenses → Other Expenses: $7.21MGross Profit → Expenses: $47.47MRevenue → Gross Profit: $47.47MRevenue → Cost of Revenue: $1.00MNet Loss → Expenses: $170.37MOther Operating Income$1.00MIncome Tax Benefit$88.00KGross Profit$47.47MNet Loss$170.37MCost of Revenue$1.00MExpenses$218.93MSelling, General & Admin$37.63MResearch & Development$174.09MOther Expenses$7.21MRevenue$48.47M

Latest period ending Dec 31, 2025 · select a line to chart its full history

GOSS annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
48.47M114.70M000
48.47M114.70M000
-170.73M-59.92M-183.76M-218.59M-216.12M
-170.37M-56.53M-179.82M-229.38M-234.00M
-60.00-20.00-94.00-217.00-250.00
GOSS annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
37.73M46.07M32.11M111.97M183.47M
172.25M315.29M311.92M272.45M343.66M
295.01M285.80M249.15M260.37M222.19M
201.97M201.92M209.16M222.76M182.34M
-122.76M29.49M62.77M12.08M121.46M
GOSS annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-171.27M-3.47M-159.16M-187.03M-188.89M
156.36M29.02M-110.97M-1.03M-117.43M
6.42M-11.49M190.15M117.09M3.33M
-79.00K00-410.00K-1.55M
-8.34M13.96M-79.86M-71.49M-303.15M